Learn how EVQLV's platform solves real-worldproblems by leveraging advances in computationto transform the design, discovery, and developmentof therapeutic antibodies
Discover the differences between EVQLV's antibody structure prediction algorithm and Google's renowned AlphaFold2.
Script not loading? Click here
Explore our cutting-edge, in silico platform and how it revolutionizes de novo antibody design.
Learn how our state-of-the-art, in silico platform humanizes a rabbit antibody, enhancing its affinity while resolving heavy-light chain pairing complexities.
Uncover how AI-generated digital signatures from EVQLV can be implemented in the amino acid sequence of an antibody, enabling the precise prediction of its epitope.